Connect
MJA
MJA

Letters

Management of healthcare workers after occupational exposure to hepatitis C virus

Patrick G P Charles, M Lindsay Grayson, Peter W Angus and Joseph J Sasadeusz

Med J Aust 2004; 180 (4): 195-196

Licensing thalidomide in Australia

Colin L Crawford

Med J Aust 2004; 180 (4): 199-200

Is grand multiparity an independent predictor of pregnancy risk? A retrospective observational study

Caroline M de Costa

Med J Aust 2004; 180 (4): 196-197

Licensing thalidomide in Australia

Martin H N Tattersall

Med J Aust 2004; 180 (4): 199-200

Is grand multiparity an independent predictor of pregnancy risk? A retrospective observational study

Michael D Humphrey

Med J Aust 2004; 180 (4): 196-197

Prevention of cardiovascular disease: an evidence-based clinical aid

Neil H Cradick

Med J Aust 2004; 180 (4): 197-198

Occupational exposure to HIV: response to a system failure

Stacey L Emmett, Adam J O’Brien and Joseph E Ibrahim

Med J Aust 2004; 180 (4): 195

Prevention of cardiovascular disease: an evidence-based clinical aid

Gregory R Fulcher, John V Amerena and Greg W Conner

Med J Aust 2004; 180 (4): 197-198

Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little

Jerome R Hoffman

Med J Aust 2004; 180 (3): 142-143

Multicentre research: negotiating the ethics approval obstacle course

Lynne M Roberts, Lucy Bowyer, Caroline S Homer and Mark A Brown

Med J Aust 2004; 180 (3): 139

Heart failure: how can we prevent the epidemic?

Matthew T Naughton, Darren R Mansfield, David M Kaye, Peter Bergin and Meroula Richardson

Med J Aust 2004; 180 (3): 143

Surveillance for Barrett’s oesophagus: if you do it, do it properly

Gautam Ramnath and Peter Bampton

Med J Aust 2004; 180 (3): 139-140

Heart failure: how can we prevent the epidemic?

Duncan J Campbell

Med J Aust 2004; 180 (3): 143

Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

Mark R Nelson

Med J Aust 2004; 180 (3): 140

Pet owners and risk factors in cardiovascular disease

Balakrishnan R Nair and Brendan Flynn

Med J Aust 2004; 180 (3): 144

Effect of computerised prescribing on use of antibiotics

Ian D Coombes, Danielle A Stowasser, Charles A Mitchell and Paul Varghese

Med J Aust 2004; 180 (3): 140-141

Pet owners and risk factors in cardiovascular disease

Michael McDonnell

Med J Aust 2004; 180 (3): 144

Palliative care: new guidelines for psychosocial care

Jane Turner, Brian McAvoy, Karen Luxford and Jane Fletcher

Med J Aust 2004; 180 (3): 141-142

Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little

David J Blacker

Med J Aust 2004; 180 (3): 142-143

The regulation of complementary health: sacrificing integrity?

Vivian Lin

Med J Aust 2004; 180 (2): 96

Overweight and obesity in Australia: an underestimate of the true prevalence?

Adrian J Cameron, Paul Z Zimmet, David W Dunstan and Jonathan E Shaw

Med J Aust 2004; 180 (2): 93-94

Aspirin for cardiovascular disease prevention

Johan H A Janssen and David Henshaw

Med J Aust 2004; 180 (2): 94

Aspirin for cardiovascular disease prevention

Joseph Hung

Med J Aust 2004; 180 (2): 94

Management of chronic suppurative otitis media

Alan E Dugdale

Med J Aust 2004; 180 (2): 91-93

The impact of chronic illness: partnerships with other healthcare professionals

Bruce Hadden

Med J Aust 2004; 180 (2): 94-95